सभी अध्ययन
भर्तीमानव फार्माकोलॉजी (चरण I) - अन्यहस्तक्षेपात्मक

A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC)

This research is an early-stage study, sometimes called a Phase I trial, looking into a new medicine called norucholic acid (NCA). We want to understand how this medicine is absorbed, used, and removed by the body in people who have a liver condition called primary sclerosing cholangitis (PSC). This information helps scientists figure out the best way to give the medicine and how much to give. It's a key first step in developing new treatments, but it's not designed to test if the medicine works to treat PSC yet. It's about safety and how the body handles the medicine.

एक नजर में

स्थिति
भर्ती
चरण
मानव फार्माकोलॉजी (चरण I) - अन्य
प्रायोजक
Dr. Falk Pharma GmbH
नामांकन लक्ष्य
33
प्रारंभ
01 Dec 2023

यह अध्ययन किस बारे में है?

This study is about a new medicine called norucholic acid (NCA) and how it behaves inside the body of people who have primary sclerosing cholangitis (PSC). PSC is a condition where the bile ducts in the liver become inflamed and scarred, which can lead to serious liver problems. Before a new medicine can be tested to see if it helps treat a condition, researchers need to understand how the body handles it.

This type of study is often one of the first steps when bringing a new medicine from the lab to patients. It helps doctors understand things like how much of the medicine the body takes in, how long it stays in the body, and how the body gets rid of it. This information is really important for deciding on the right dose and how often the medicine should be given in future, larger studies.

The main goal here is not to see if NCA cures PSC, but to gather important information about how it interacts with the human body. This foundational knowledge is crucial for the safe and effective development of new treatments for PSC in the future.

मुख्य निष्कर्ष

  • This is an early-stage study for a new medicine for PSC patients.
  • It aims to understand how norucholic acid (NCA) moves through the body.
  • The study includes adults aged 18 and over, both men and women.
  • It is not testing if the medicine cures PSC, but gathering crucial information for future studies.
  • Participation involves taking the medicine and having regular check-ups and blood tests.
  • आप किसी भी समय अध्ययन से हट सकते हैं।.

कौन पात्र हो सकता है?

This study is open to both men and women. To take part, you need to be at least 18 years old. There is no upper age limit for joining this study, so older adults are also welcome if they meet other health requirements.

Because this is a very early study looking at how a new medicine moves through the body, researchers will have specific health checks to make sure it's safe for you to take part. These checks would include reviewing your medical history and current health.

You would need to have a diagnosis of Primary Sclerosing Cholangitis (PSC) to be considered for this study. The medical team would discuss all the specific details with you to see if the study is a good fit for your situation.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. क्या आप 18 वर्ष या उससे अधिक आयु के हैं?
  2. Do you have a diagnosis of Primary Sclerosing Cholangitis (PSC)?
  3. क्या आप नियमित क्लिनिक अपॉइंटमेंट्स में शामिल हो सकते हैं?
  4. Are you willing to take a new, unapproved medicine?
  5. Are you comfortable with having blood samples taken periodically?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

If you decide to take part in this study, you would be given the new medicine, norucholic acid (NCA). The study would involve several visits to a clinic or hospital. During these visits, the research team would likely take blood samples at different times to measure how much of the medicine is in your body and how long it stays there. They might also check your vital signs like blood pressure and heart rate, and ask about any side effects you might be feeling.

The total length of time you would be involved in the study would be explained to you in detail. This type of study usually involves a period of taking the medicine and then follow-up appointments to make sure everything is okay. All your appointments and assessments would be carefully planned and communicated.

संभावित जोखिम और लाभ

Like any medical study, there could be some potential benefits and some potential risks to taking part. A potential benefit is that you would receive a new investigational medicine that might, in the future, help with PSC, though this study isn't designed to show treatment effects. You would also be closely monitored by medical professionals, and your participation helps advance medical science, potentially leading to new treatments for others. However, there's always a risk of side effects from any new medicine, and some procedures like blood tests can cause minor discomfort or bruising. You are always free to leave the study at any time, for any reason, without it affecting your usual medical care.

स्थान (4)

कुछ साइट स्थान अनुमानित हैं। हम इसे सुधार रहे हैं — कृपया यात्रा करने से पहले परीक्षण टीम से सत्यापित करें।.
  • —
    असत्यापित
    जर्मनी
  • —
    असत्यापित
    ऑस्ट्रिया
  • —
    असत्यापित
    फिनलैंड
  • —
    असत्यापित
    नॉर्वे

सामान्य प्रश्न

What is Primary Sclerosing Cholangitis (PSC)?

PSC is a long-term liver disease that damages the small tubes (bile ducts) inside your liver, which can lead to scarring and affect how your liver works.

What does 'Human Pharmacology (Phase I)' mean?

It means this is a very early study in people, focusing on understanding how a new medicine behaves in the body and checking for its safety, rather than if it cures a disease.

Will this medicine cure my PSC?

This particular study is not designed to see if the medicine treats or cures PSC. Its main purpose is to understand how the medicine works in the body and its safety at an early stage.

क्या मुझे अध्ययन में शामिल होने के लिए भुगतान करना होगा?

No, you should not have to pay to participate in a clinical trial. Any study-related care and medicines would typically be provided at no cost to you.

What is 'norucholic acid (NCA)'?

NCA is the name of the new medicine being studied. At this stage, it's an 'investigational' medicine, meaning it's still being researched and is not yet available as a standard treatment.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

भाग लेने में रुचि रखते हैं?

अपनी रुचि दर्ज करें

अपने विवरण साझा करें और अनुसंधान टीम के लिए "A study to characterize the pharmacokinetic profile of noruc…यदि आप पात्र हो सकते हैं तो आपसे संपर्क करेंगे। भाग लेने के लिए सहमति देने से पहले हमेशा अपने जीपी से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.